Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Not applicableStudy completedNCT01898403
What this trial is testing

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Who this might be right for
Recurrent Melanoma
Stanford University 50
Testing effectiveness (Phase 2)WithdrawnNCT06508827
What this trial is testing

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Who this might be right for
Anemia, Iron DeficiencyMelanoma
Indiana University
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Testing effectiveness (Phase 2)Temporarily pausedNCT01988831
What this trial is testing

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

Who this might be right for
Stages III Skin MelanomaStages II Skin MelanomaStage IB Skin Melanoma
University Hospital, Geneva 450
Not applicableEnded earlyNCT02236546
What this trial is testing

FDG-PET in Advanced Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05907954
What this trial is testing

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 160
Testing effectiveness (Phase 2)Ended earlyNCT04894994
What this trial is testing

FLX475 in Combination With Ipilimumab in Advanced Melanoma

Who this might be right for
Advanced Melanoma
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 6
Testing effectiveness (Phase 2)UnknownNCT00746746
What this trial is testing

A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma

Who this might be right for
Melanoma
Ochsner Health System 30
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Not applicableUnknownNCT02335476
What this trial is testing

Automatic Early Melanoma Detection by Ultrahigh Resolution Three Dimensional Optical Coherence Tomography

Who this might be right for
Melanoma
National Taiwan University Hospital 100
Not applicableStudy completedNCT01338389
What this trial is testing

Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy

Who this might be right for
Uveal Melanoma
Centre Hospitalier Universitaire de Nice 21
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableUnknownNCT02884362
What this trial is testing

Prospective Melanoma Database

Who this might be right for
Melanoma
Institut Claudius Regaud 10,000
Not applicableStudy completedNCT02651246
What this trial is testing

Optional Sub-study to Intraoperative Imaging With ICG Registry

Who this might be right for
Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) CancerCancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma CancerCancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer
Abramson Cancer Center at Penn Medicine 291
Testing effectiveness (Phase 2)Ended earlyNCT02080962
What this trial is testing

Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer

Who this might be right for
Non-melanoma Skin Cancer
Barretos Cancer Hospital 10
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Not applicableStudy completedNCT02600169
What this trial is testing

Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab

Who this might be right for
Melanoma
University Medical Center Groningen 150
Testing effectiveness (Phase 2)Study completedNCT01216696
What this trial is testing

Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1

Who this might be right for
Metastatic Melanoma
National Center for Tumor Diseases, Heidelberg 25
Next Page